India allows COVID-19 vaccine trial on children aged 7-11

File Picture

India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol children aged 7-11 years for its COVID-19 vaccine trial as the country prepares to protect kids from the coronavirus.

It has already administered more than 870 million doses to adults among its population of nearly 1.4 billion.

"After detailed deliberation, the committee recommended for allowing enrolment of subjects of 7 to 11 years of age group as per the protocol," a subject expert panel of the Central Drugs Standard Control Organisation said.

Serum Institute is already conducting a trial of its COVID-19 vaccine, a domestically produced version of US drugmaker Novavax's shot, in the 12-17 age group and has presented safety data for an initial 100 participants.

So far, only drugmaker Zydus Cadila's DNA COVID-19 vaccine has received emergency use approval in India to be used in adults and children aged 12 years and above.

More from International News

On Virgin Radio today

Trending on Virgin Radio

  • ARN News Centre

    Get the latest UAE and world news from our award winning team of journalists. The ARN News Centre is the country's most trusted source of information.

  • Middle East Hot 30

    Every weekend Kris Fade plays the biggest tracks in the Middle East. Check out this weeks chart...

  • Jason Derulo on the Kris Fade Show!

    The super-star and multi-award-winning singer-songwriter, Jason Derulo is bringing the heat to Dubai.

  • Ed Sheeran - UAE EXCLUSIVE

    Latest album, what happened with BTS, raising a baby girl, eye surgery, and more!